These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16934337)

  • 1. Antibodies as biological markers for pathophysiological processes in MS.
    Reindl M; Khalil M; Berger T
    J Neuroimmunol; 2006 Nov; 180(1-2):50-62. PubMed ID: 16934337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple sclerosis: disease biomarkers as indicated by pathophysiology.
    Berger T; Reindl M
    J Neurol Sci; 2007 Aug; 259(1-2):21-6. PubMed ID: 17367811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B cells and antibodies in MS.
    Reindl M; Kuenz B; Berger T
    Results Probl Cell Differ; 2010; 51():99-113. PubMed ID: 19513636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological markers in multiple sclerosis: tackling the missing elements.
    Rinaldi L; Gallo P
    Neurol Sci; 2005 Dec; 26 Suppl 4():S215-7. PubMed ID: 16388362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homogeneity of active demyelinating lesions in established multiple sclerosis.
    Breij EC; Brink BP; Veerhuis R; van den Berg C; Vloet R; Yan R; Dijkstra CD; van der Valk P; Bö L
    Ann Neurol; 2008 Jan; 63(1):16-25. PubMed ID: 18232012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunopathogenic and clinical relevance of antibodies against myelin oligodendrocyte glycoprotein (MOG) in Multiple Sclerosis.
    Berger T; Reindl M
    J Neural Transm Suppl; 2000; (60):351-60. PubMed ID: 11205153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies against light neurofilaments in multiple sclerosis patients.
    Bartos A; Fialová L; Soukupová J; Kukal J; Malbohan I; Pitha J
    Acta Neurol Scand; 2007 Aug; 116(2):100-7. PubMed ID: 17661795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An update on multiple sclerosis.
    Hauser SL
    J Neurol Sci; 2005 Feb; 228(2):193-4. PubMed ID: 15694203
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibodies to myelin oligodendrocyte glycoprotein as a biomarker in multiple sclerosis--are we there yet?
    Amor S; Giovannoni G
    Mult Scler; 2007 Nov; 13(9):1083-5. PubMed ID: 17967836
    [No Abstract]   [Full Text] [Related]  

  • 10. Lack of association between antimyelin antibodies and progression to multiple sclerosis.
    Berger T; Reindl M
    N Engl J Med; 2007 May; 356(18):1888-9; author reply 1888-9. PubMed ID: 17476020
    [No Abstract]   [Full Text] [Related]  

  • 11. An N-glucosylated peptide detecting disease-specific autoantibodies, biomarkers of multiple sclerosis.
    Lolli F; Mulinacci B; Carotenuto A; Bonetti B; Sabatino G; Mazzanti B; D'Ursi AM; Novellino E; Pazzagli M; Lovato L; Alcaro MC; Peroni E; Pozo-Carrero MC; Nuti F; Battistini L; Borsellino G; Chelli M; Rovero P; Papini AM
    Proc Natl Acad Sci U S A; 2005 Jul; 102(29):10273-8. PubMed ID: 16014416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-cell responses to myelin antigens in multiple sclerosis; relevance of the predominant autoimmune reactivity to myelin oligodendrocyte glycoprotein.
    de Rosbo NK; Ben-Nun A
    J Autoimmun; 1998 Aug; 11(4):287-99. PubMed ID: 9776706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood test may predict MS progression.
    Health News; 2003 Sep; 9(9):5-6. PubMed ID: 14584469
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification of autoantibodies associated with myelin damage in multiple sclerosis.
    Genain CP; Cannella B; Hauser SL; Raine CS
    Nat Med; 1999 Feb; 5(2):170-5. PubMed ID: 9930864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple sclerosis.
    Hafler DA; Slavik JM; Anderson DE; O'Connor KC; De Jager P; Baecher-Allan C
    Immunol Rev; 2005 Apr; 204():208-31. PubMed ID: 15790361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiplexing approaches for autoantibody profiling in multiple sclerosis.
    Somers K; Govarts C; Stinissen P; Somers V
    Autoimmun Rev; 2009 Jun; 8(7):573-9. PubMed ID: 19393211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody responses against galactocerebroside are potential stage-specific biomarkers in multiple sclerosis.
    Menge T; Lalive PH; von Büdingen HC; Cree B; Hauser SL; Genain CP
    J Allergy Clin Immunol; 2005 Aug; 116(2):453-9. PubMed ID: 16083805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pathogenesis of primary progressive multiple sclerosis: antibody-mediated attack and no repair?
    Pender MP
    J Clin Neurosci; 2004 Sep; 11(7):689-92. PubMed ID: 15337125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecules affecting myelin stability: a novel hypothesis regarding the pathogenesis of multiple sclerosis.
    Mastronardi FG; Moscarello MA
    J Neurosci Res; 2005 May; 80(3):301-8. PubMed ID: 15704220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do myelin-directed antibodies predict multiple sclerosis?
    Antel JP; Bar-Or A
    N Engl J Med; 2003 Jul; 349(2):107-9. PubMed ID: 12853581
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.